PMID: 6102965Jan 1, 1980Paper

Inhibition of angiotensin II potentiation of sympathetic nerve activity by beta-adrenergic antagonists

Hypertension
E K Jackson, W B Campbell

Abstract

Since beta-adrenergic blockers are effective in the therapy of hypertension by a mechanism related to the degree of activation of the renin-angiotensin system, the effect of eight beta blockers was examined on angiotensin II potentiation of nerve stimulation (NS) in isolated perfused rat mesenteric vessels. The vasoconstrictor response to periarterial NS was obtained by monitoring changes in perfusion pressure while a beta blocker or a beta blocker and angiotensin II (3 ng/ml) were added to the perfusate. Although each beta blocker tended to decrease responses to NS, in the concentrations used, only metoprolol significantly inhibited responses to NS. Angiotensin II, when infused alone, potentiated the responses to NS by 63% (p less than 0.01). These enhanced responses following angiotensin II were inhibited in a dose-related manner (10--300 ng/ml) by beta 1, beta 2, and mixed beta blockers. At the 100 ng/ml concentration, DL-propranolol, timolol, metoprolol, practolol, butoxamine, and H35/25 inhibited the angiotensin II potentiation of NS by 83%, 76%, 77%, 59%, 72%, and 41% respectively. The order of potency for this action was as follows: timolol = metoprolol = butoxamine greater than propranolol greater than practolol greater...Continue Reading

References

Oct 1, 1977·Physiological Reviews·T C Westfall
Sep 1, 1977·Clinical Pharmacology and Therapeutics·M EslerV DeQuattro
Dec 1, 1978·Clinical Pharmacology and Therapeutics·T WalleT E Gaffney
Jul 8, 1976·The New England Journal of Medicine·J W HollifieldD G Shand
Feb 15, 1977·Life Sciences·M FernandesC Swartz
Jan 1, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·K H RahnG Planz
May 1, 1967·The Journal of Physiology·C J DICKINSON, R Yu
Feb 1, 1971·British Journal of Pharmacology·J Hughes, R H Roth
Nov 1, 1970·The Journal of Pharmacy and Pharmacology·A M Barrett, B Nunn
Sep 1, 1974·Clinical Pharmacology and Therapeutics·H SundquistM Arstila
Jun 25, 1966·Nature·R Howe, R G Shanks
Feb 4, 1963·Annals of the New York Academy of Sciences·J P BUCKLEYH KATO

Citations

Aug 29, 1980·European Journal of Pharmacology·E K Jackson, W B Campbell
Apr 1, 1985·Pharmacology, Biochemistry, and Behavior·M J Katovich, C C Barney
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·M NiwaJuan M Saavedra
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·D C EikenburgM F Lokhandwala
Jan 28, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Kartikya Ahuja, Mitchell H Charap

Related Concepts

Adrenergic beta-Antagonists
Angiotensin II, Val(5)-
Drug Interactions
Drug Augmentation
Electric Stimulation Technique
Norepinephrine, (+, -)-Isomer
Rexigen
Sympathetic Nervous System
Synapses
Timoptol

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.